GSK Says Trial of Itch Treatment Linerixibat Meets Primary Endpoint
Statement: GSK Continues to Show Strong Leadership in Its Access to Medicines Index Ranking
Linerixibat Shows Positive Phase III Results in Cholestatic Pruritus (Relentless Itch) in Primary Biliary Cholangitis (PBC)
Express News | Us CDC Says Since April Confirmed Avian Influenza A(H5) Virus Infections In 52 People In US; Aware Of Human Case Of H5N1 Bird Flu Reported In Canada & Is In Communication With Public Health Agency Of Canada
Global Companies With at Least 50% U.S. Revenue Exposure as Trump Eyes Tariffs: BofA
Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer
